Trials / Completed
CompletedNCT01043445
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.
G Protein-coupled Receptor in the Intestine (GPR 119) Stimulated GLP-1 Secretion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the impact of different ligands of GPR 119 (a G protein-coupled receptor in the intestine) on the secretion of the incretin hormones, GLP-1 and GIP.
Detailed description
We have found a new ligand for the GPR 119 receptor. This study evaluate the impact of this ligand on the incretion hormone responses, beta cell function and gall bladder function in healthy young men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | GPR 119 agonist, 2-oleyl glycerol | Emulgation, 50 ml. containing 2g 2OG |
| DIETARY_SUPPLEMENT | Oleic acid | Emulgation, 50 ml. containing 1.54g of oleic acid |
| DIETARY_SUPPLEMENT | Vehicle | Fifty milliliters of glycerol (Sigma-Aldrich; batch 32296AK, purity 99%) plus 5 ml 96% ethanol |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2010-01-06
- Last updated
- 2014-10-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01043445. Inclusion in this directory is not an endorsement.